Categories

-

Arthritis :: Turmeric supplements show promise in treating arthritis

October 30, 2006

More than 40 percent of arthritis sufferers in the U.S. report using complementary and alternative medicine, including dietary supplements, and the use of alternative remedies has increased since the FDA issued health warnings about anti-inflammatory drugs such as Celebrex.

However, the effectiveness of many supplement ingredients has not been adequately studied.
To complicate the matter, over-the-counter supplements are not regulated in the same way as drugs and their composition can vary widely.

Drugs Online - Buy Drugs Online at reasanoble prices.DrugOnline.cc provides confortable and easy way to order drugs online including drugs free shipping.

A new study published in the November 2006 issue of Arthritis & Rheumatism examined the effect and mechanism of turmeric (a botanical supplement long thought to have anti-inflammatory properties) on arthritis.

Posted by toshko under Pain Relief News | Comments (0)

Progenics Pharma Receives Payment Of $5 Mln From Wyeth’s Unit Wyeth Pharmaceuticals For Phase 3 Trial Of Methylnaltrexone- Update

October 25, 2006

Early Wednesday, Progenics Pharmaceuticals, Inc. (PGNX | charts | news | PowerRating), a biopharmaceutical company, revealed that it has earned $5 million payment from Wyeth’s (WYE | charts | news | PowerRating) unit Wyeth Pharmaceuticals under the companies’ collaborative agreement to develop and commercialize methylnaltrexone. The company noted that the payment was made, following the beginning of the company’s Phase 3 clinical trial of intravenous methylnaltrexone for the treatment of post-operative ileus or POI, a debilitating impairment of the gastrointestinal tract that occurs after surgery. According to the company, under the agreement terms, it has the potential to receive about $356.5 million, payable upon achievement of certain milestones.

Methylnaltrexone is an investigational drug that is designed to treat the peripheral side effects of opioid analgesics without interfering with pain relief. Post-operative ileus is a major contributor to prolonged hospital stays and therefore represents an important cause of increased health care costs. Postoperative patients cannot tolerate oral intake, including medications, therefore intravenous methylnaltrexone would represent an important therapy for these patients.

Discount Pharmacy - Buy Pharmacy at discount prices including free shipping.Discount Pharmacy provides confortable and easy way to order discount pharmacy online.

The company noted that in the Phase 2 study, the patients who received methylnaltrexone, after undergoing segmental colectomy surgery, exhibited an acceleration of gastrointestinal recovery by at least one day on average compared to placebo. Methylnaltrexone was generally well tolerated in this study, with no reports of serious adverse events related to the drug.

The company noted that the earlier announced phase 3 clinical study of intravenous methylnaltrexone in POI is enrolling about 500 patients who have undergone segmental colectomy surgery in a double-blind, randomized, placebo-controlled clinical trial at about 90 surgical centers worldwide. The company said that the key elements of the study design, which includes the primary efficacy endpoint, were reviewed with the U.S. Food and Drug Administration or FDA under a Special Protocol Assessment in July 2006. In this trial, study medication is administered following surgery and every six hours until the patient recovers gastrointestinal function or for up to 10 days after surgery, said the company.

The company further added that Methylnaltrexone has already received Fast Track designation from the FDA. Fast Track designation would facilitate development and may expedite regulatory review of drugs that FDA recognizes as potentially addressing an unmet medical need for serious or life-threatening conditions. The company said that a New Drug Application is planned for intravenous methylnaltrexone in late 2007 or early 2008, subject to the satisfactory completion of the planned second global phase 3 study, which is estimated to begin later this year.

PGNX closed Tuesday’s regular trading session at $24.67, down $0.59. WYE closed yesterday’s regular trade at $52.32, up $0.47, on a volume of 6.98 million shares.

Posted by toshko under Pain Relief News | Comments (0)

Want chronic-pain relief ? It helps to be rich

October 24, 2006

The pain started 20 years ago, after Larry Cross was checked from behind playing hockey and ruptured a disc. Doctors repaired his spine in a dozen separate operations, eventually reinforcing it with steel, but the pain grew so intense he could barely cope.

Morphine or other drugs only worked if he took them in doses so high he felt comatose. He was bedridden, depressed and shunning the people who loved him the most: “I was on the verge of suicide. I did not want to wake up the next morning.”

In 2001, his doctor recommended he travel to the United States to have a morphine pump surgically implanted in his abdomen that would send the drug through a catheter to his spine. He was lucky to be wealthy — the surgery cost $35,000 — and lucky that it worked.

The pumps are effective for only 40 per cent to 50 per cent of those who try them, and success is defined as a 25-per-cent reduction in pain.
Related to this article
Larry Cross examines an X-ray of his lower back: To relieve chronic pain, he paid for a U.S. operation to have a morphine pump implanted. Fred Lum/The Globe and Mail
Enlarge Image

Larry Cross examines an X-ray of his lower back: To relieve chronic pain, he paid for a U.S. operation to have a morphine pump implanted. (Fred Lum/The Globe and Mail)
Articles Related Articles

“It felt wonderful,” said the 66-year-old retiree, who lives near Guelph, Ont., and once owned several plants that manufactured auto parts. His pain dropped from 10 out of 10 to a five on his good days, a level he can live with. “I cannot tell you how much it gives you your life back.”

More than five million Canadians live with chronic pain; surveys suggest between 15 per cent and 29 per cent are in severe pain. Many can only dream of getting their lives back, because they don’t have the cash to pay for private pain relief, either in the United States or Canada.

The kind of surgery Mr. Cross had done in the United States is very difficult to get in many parts of Canada, as are other procedures that can help with chronic, intractable pain. Spinal cord stimulators are also implanted surgically, and use a mild electric current to numb pain. Deep brain stimulation involves implanting electrodes — either on the membrane that protects the brain or inside the brain itself.

These procedures should be used as a last resort, doctors say, after drugs and other treatments have been tried. But many patients with chronic pain face difficulties getting any kind of help, let alone surgery.

Most doctors get almost no training in pain control, says Roman Jovey, president of the Canadian Pain Society, a group of doctors and researchers involved in treating and studying pain.

Physicians often don’t have enough time to deal with complicated and difficult cases of patients with chronic pain, who are more at risk of suffering from depression and sleep disorders. The patients can have trouble finding a general practitioner who will take them on.

Many doctors are nervous about prescribing morphine or other opioid drugs, for fear they will face scrutiny or sanctions from their provincial governing bodies, says James Henry, scientific director of the Michael G. DeGroote Institute for Pain Research and Care at McMaster University in Hamilton.

He is doing a study to determine the best way to get the latest information on pain control to GPs — either a telephone hotline or a website.

For many patients, their best chance for relief is getting treatment from specialists who know all the options and understand the psychological and social factors that influence pain. They tend to work at pain management clinics, where patients can get access to medication, physiotherapy or treatments like acupuncture, and help with the problems chronic pain causes in their personal lives. But many hospitals don’t have a pain clinic, says Dr. Henry.

“That is a disgrace,” he says.

Drugs Online - Buy Drugs Online at reasanoble prices.DrugOnline.cc provides confortable and easy way to order drugs online including drugs free shipping.

He specializes in the study of nerves, but like many researchers or doctors in the chronic pain field, he has become an advocate for patients who, he says, are shamefully neglected by the health-care system. “The basic science grabs my mind, but the human side grabs my heart,” he says. “I get impassioned when I see this level of suffering and this level of undertreatment by what I would like to think of as a wonderful health-care system.”

Many clinics have waiting lists of six months to five years. But people with private funding — from an insurance company after a motor vehicle accident, through compensation from a workplace injury, or out of their own pockets — can get into clinics in three weeks, according to a study conducted by Philip Peng at Toronto Western Hospital. “There is no doubt there is a two-tier system,” he says.

Seeing a specialist quickly is extremely important, says Dr. Jovey. Researchers have shown that chronic pain progresses into a disease of its own, and is not simply a symptom of another illness, like arthritis or shingles. “The patient progresses further and further into disability the longer the pain is not managed.”

Patients with chronic pain are starting to organize, and lobby politicians across the country for better access to care. The Canadian Pain Coalition was formed in 2002 to bring together patient groups, health-care professionals who care for people in pain, and researchers. It is organizing National Pain Awareness Week, from Nov. 5 to 11.

Mr. Cross has been lobbying politicians in Ontario so that others — rich or poor — can have access to a morphine pump. But his story shows that having money can make a huge difference in the kind of care a patient receives.

Shortly after he had his surgery in the U.S., he learned that the procedure was being performed in Canada, including in Ontario. He knew he would need another surgery. The pumps only last about five years, and then they need to be replaced. Earlier this year, it became clear that his was wearing out. He was getting overdoses.

“My wife would find me comatose on the floor.”

He was scheduled to have it replaced at St. Joseph’s Hospital in Hamilton on Monday, April 3. On the Friday before, he says the hospital informed him the surgery was off because it wouldn’t pay for the pump.

So he ordered one using his Visa card, paying about $12,000 for the device. He was desperate. His surgeon was going away for a month, so the hospital agreed the surgery — with his privately purchased pump — could go ahead.

Hospital president and CEO Kevin Smith says it was the “right and humane” thing to do. But Mr. Cross’s case prompted a debate among doctors and hospital administrators about whether patients who can pay for morphine pumps — or other expensive treatments — should be able to get them at a publicly funded hospital.

The hospital now has a new policy. The 20 patients who already have pumps can get morphine top-ups every three months, and replacements when required. But new patients won’t get a pump unless the devices are paid for by third-party insurance. That leaves only one hospital in Ontario, Toronto Western, where new patients can get a pump paid for through a hospital budget, says Dr. Peng.

Anyone else in the province who needs one is out of luck — unless they can afford to pay for surgery in the United States.

Posted by toshko under Pain Relief News | Comments (0)

Pioneering treatment for chronic pain

October 19, 2006

One in six people in Ireland are now affected by chronic pain. However the pain management clinic at St Vincent’s University Hospital in Dublin is celebrating the successful treatment of 100 patients with pioneering technology, which has never been used outside of the US before.

Chronic pain is a long-term, complex condition that affects people biologically, physiologically and socially. At least two in three sufferers experience pain on a daily basis. This pain may affect one or two areas of the body, however some people experience pain throughout their body. In extreme cases, patients have been confined to a wheelchair.

Neuromodulation treats chronic pain without drugs by using electricity to modify the body’s response to pain. It works by precisely delivering tiny electrical signals to the spinal cord that mask pain signals as they travel to the brain, creating instead a tingling sensation.

This spinal cord stimulation is prescribed for patients with chronic pain in the limbs, trunk and back who have not received adequate pain relief from physical therapy, pain medication or prior surgeries.

Discount Pharmacy - Buy Pharmacy at discount prices including free shipping.Discount Pharmacy provides confortable and easy way to order discount pharmacy online.

The pain management clinic at St Vincent’s is the first clinic to use this technology outside of the US. Neuromodulation was first used here in October 2005 and since then, 100 patients have benefited from the treatment.

“The social and economic impact of chronic pain is immense. Recent findings in terms of just one form of chronic pain, in the lower back, show the burden to State resources - €28 million in hospital resources, disability payouts of €348 million and insurance payouts of €1.05 million”, explained Dr Declan O’Keeffe, clinical director of St Vincent’s pain management clinic.

It is now estimated that a person with chronic pain will miss an average of 17 working days per year as a result of the condition.

According to Dr O’Keeffe, the patients that have been treated with this pioneering technology have seen a dramatic improvement in their everyday lives.

“The clinical need in Ireland for neuromodulation is approaching 480 per year. Collectively, all institutions in Ireland would perform only about 250, with the bulk of these at St Vincent’s. This record needs to be improved with greater health resources, awareness of the treatment options and clinical expertise”, Dr O’Keeffe added.

Posted by toshko under Pain Relief News | Comments (0)

Mind over matter can ease suffering

October 16, 2006

Nola Schmidt knows about pain, especially children’s pain.

The Valparaiso University nursing professor used to care for children with sickle cell disease and cancer, medical conditions long known to be associated with significant pain.
» Click to enlarge image
Nola Schmidt in her office on Valparaiso University’s campus. Schmidt was awarded a grant to conduct a pain studies on patients at Children’s Memorial Medical Center in Chicago.
Stephanie Dowell/Post Tribune

“Treating pain was important for these children,” said Schmidt from her office in the School of Nursing’s LaBien building near Porter hospital.

Schmidt, who devoted her doctoral dissertation to the subject, was awarded a $20,000 Shaw Nursing Faculty Collaborative Grant two years ago to study children’s pain.

She hoped to find out if kids using their imaginations, in place of pain medication, was effective.

So-called “guided imagery” is the use of the subconscious mind to conjure up or imagine pleasant thoughts to help relieve pain, stress and other conditions.

While not dramatic, the findings did show results.

“What I can say is that it’s clinically significant. The kids who used guided imagery used less pain medication.”

The study involved 17 patients at Chicago’s Children’s Memorial Hospital, ages 7 to 16.

Schmidt’s pain research team created pain “diaries” for young patients to fill out.

The team collected 25 diaries containing 236 entries over a two-year period.

Of the children in the control group, the average pain score was lower than the group that did not use guided imagery.

Researchers looked at how much pain medication the children used every day, converting it to an equal dose of morphine.

They talked to each child and created individualized audiotapes, ranging from 5 to 15 minutes, to help them with visualization to ease their pain.

“Then the kids were left a tape player and headphones so they could play the tape whenever they wanted to,” Schmidt said.

Most of the tapes suggested patients close their eyes, relax, take a deep breath and imagine a favorite place, then describe what they saw, heard, tasted and smelled.

The team designed a journal for each child so they could make specific entries about where they felt pain, the degree of pain and what different methods they used to relieve their pain.

“The kids reported that they enjoyed it,” Schmidt said. “We got a good response from both parents and kids in the diaries.

Drugs Online - Buy Drugs Online at reasanoble prices.DrugOnline.cc provides confortable and easy way to order drugs online including drugs free shipping.

“The tragedy is that there are a lot of pain-relief strategies out there, but kids, and adults, are still having pain,” Schmidt said. “We, as health care workers, need to do a better job of addressing pain,” she said. “It’s an important issue.”

Schmidt believes that pain medication will continue to be the No. 1 pain treatment.

“The problems, of course, are the side effects. We need to find complementary things to help pain without giving such big doses,” she said.

Schmidt served as team leader for four other nurses heading up the study at Children’s Memorial. Over two years, eight staff nurses and a research assistant worked on the research project.

Diane Calamaras, a certified pediatric nurse practitioner in the hospital’s Hematology/Oncology Division, was part of the team.

“From a hematology perspective, we have sickle cell patents who are often admitted for pain. I absolutely agree with Dr. Schmidt that guided imagery is a very useful way to help children with pain.

“I felt that the kids using the guided imagery were happy to use it,” Calamaras said. “They had great diaries.”

Calamaras said the team planned to discuss introducing guided imagery to other patients.

“I think more research is needed, and I would be happy to do that,” she said.

Schmidt said she and her team hope to mass produce the diaries so they would be available to whoever might want them. They also plan to publish their findings and present them at professional conferences.

They have already presented their results at Children’s Memorial and in Johannesburg, South Africa, in July at the Ninth World Congress on Self Care.

Dr. Santanam Suresh, anesthesiologist and co-director of the Chronic Pain Treatment Program at Children’s Memorial, said the study of guided imagery to manage pain warrants further study.

“Looking at this would be ideal,” Suresh said. “The problem is the consistency with which the provider can provide guided imagery. It’s not going to be easy with different age groups. There are limitations to the study.”

However, Suresh said, “It’s like the application of yoga or meditation, which have been around for thousands of years, but people are just now discovering the advantages of something like this.

This is one of those things that people should start paying attention to,” Suresh said.

“As we move forward into the new millennium we have to understand we just can’t depend on commercial remedies for pain management,” Suresh said. “We have to think of alternative remedies, too.”

Posted by toshko under Pain Relief News | Comments (0)

ANS receives Australian approval for rechargeable chronic pain system

October 11, 2006

Advanced Neuromodulation Systems (ANS), the neuromodulation business of St. Jude Medical, Inc. has announced Australian Therapeutic Goods Administration (TGA) regulatory approval for its Eon Rechargeable Neurostimulation System. In Australia, the Eon system is fully reimbursable via the private health system.

Patients at the Pain Management Research Institute, Royal North Shore Hospital in Sydney, were among the first to receive the Eon system. Pain Medicine Specialist Professor Michael Cousins, M.D., who performed one of the first surgeries, said, “Eon was easy to implant and the patients continue to gain substantial pain relief. With its rechargeable battery, Eon is a good option for patients who require high-power stimulation settings and need to use the system for a large percentage of the day.�
Eon delivers spinal cord stimulation (SCS) therapy to treat chronic, intractable pain of the trunk and limbs, including pain associated with failed back surgery syndrome. Similar to a cardiac pacemaker, this “pacemaker for pain� uses mild electrical pulses from leads selectively placed near the spinal cord to interrupt pain signals to the brain.
Eon contains the highest-capacity rechargeable battery available, which is designed to last a minimum of seven years at high-power settings.

Discount Pharmacy - Buy Pharmacy at discount prices including free shipping.Discount Pharmacy provides confortable and easy way to order discount pharmacy online

This allows patients to go longer between battery replacement surgeries. The rechargeable technology is easy for patients to understand and use – they simply recharge the device periodically, similar to recharging a mobile phone. Eon can power up to 16 independent electrodes, which allows clinicians more programming options to better manage the patient’s pain.

“Approval of the Eon system provides physicians in Australia with a new tool to combat chronic pain,� said Chris Chavez, president of ANS. “The full power of the Eon system is realized when coupled with advanced clinician programming features of Rapid Programmer 3.0, such as Dynamic MultiStim and Active Balancing. Eon and this programming platform work together as an integrated system to provide clinicians greater speed, precision and effectiveness in addressing complex pain.�
Chronic pain is a largely under-treated and misunderstood disease that affects millions of people worldwide. The World Health Organization, in conjunction with the International Association for the Study of Pain (IASP), reports that “One in five people suffers from moderate to severe chronic pain, and one in three is unable or less able to maintain an independent lifestyle due to pain.� Spinal cord stimulators like Eon often allow patients to greatly reduce their need for potent and potentially addictive pain medication.

Eon was approved by the U.S. Food and Drug Administration in 2005. Approximately 25,000 patients in more than 25 countries around the world use ANS neurostimulation devices to manage chronic pain.

Posted by toshko under Pain Relief News | Comments (0)

Research for Back Pain Relief Strikes Gold

October 10, 2006

An engineering student from the University of Manchester Been honored with a prized award for research that could be the harbingerof hope for millions who suffer from chronic or acute back pain worldwide.

The Morgan Crucible prize awarded to the Best Materials Student annually at the Science, Engineering and Technology Student of the Year Awards has been bagged by Racheal Ambury.

She examined how special ‘Braces’ or ‘Scaffolds’ could be implemented in the treatment of slipped discs and other chronic debilitating disorders triggering off anguishing back pain in her final year assignment. Her work based on tissue engineering was commended greatly by the panel of judges.

Drugs Online - Buy Drugs Online at reasanoble prices.DrugOnline.cc provides confortable and easy way to order drugs online including drugs free shipping.

The work of another Ph.D student on Back Pain was the source of insight for Ms.Racheal. Involving an engineering process known as electro spinning, she evolved a series of ‘’bioresorbable’’ polymer scaffolds. These scaffolds when surgically implanted are to hold tissues together hastening cell repair and regeneration. Bioresorbable scaffolding, which in due time dissolves is beneficial to patients in the long run as they hasten the healing process and therefore, cuts time and cost of treatment efficiently.

Chronic back problems are reported to affect two thirds of adults and an estimated loss running into billions of pounds is the result in the UK.

During the course of her work, Ms.Racheal studied the biological and physical impact of using diverse scaffolds.

Her tutors nominated her for her stupendous work in June 2006.In September 2006 she was invited to present her thesis before a panel of eminent judges. She received her award at an impressive ceremony at the Royal Courts of Justice.

Posted by toshko under Pain Relief News | Comments (0)